Skip to main content

ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

van der Veen BS, Heeringa P. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models? APMIS 2009; 117: 21–6.

Anti-neutrophil cytoplasmic autoantibodies (ANCA) with a specificity for myeloperoxidase or proteinase 3 are closely associated with small vessel vasculitides (SVV). In vitro, ANCA activate primed neutrophils to release toxic substances that destroy endothelial cells, suggesting a pathogenic role for these autoantibodies in disease development. However, to study the complex interplay between ANCA, neutrophils, and the local environment in vivo, animal models are required. Here, we will review the animal models developed for ANCA-SVV and discuss how these models have been applied to study ANCA-SVV pathogenesis. In addition, some directions for future research pertaining to unresolved issues relevant for the pathogenesis and immunogenesis of ANCA-SVV are proposed.

Keywords: ANCA; animal models; review; vasculitis

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1600-0463.2009.02472.x

Affiliations: Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Publication date: 2009-06-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more